Skip to main content
In stock | Immunotherapy (Bispecific Antibody)

Epcoritamab

Oncology Type Both (Solid & Hematologic)
Drug Class / Mechanism Bispecific T-Cell Engager
No Image
Description

Epcoritamab is classified as a Bispecific T-Cell Engager, sourced for use within our Immunotherapy (Bispecific Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Immunotherapy (Bispecific Antibody)
Oncology Type Both (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3